郑州初三复读哪里有地方长安区中学补习学校靠谱的效果好,陕西回流生哪里有怎么样,鄠邑区高三学校正规地方,长安区封闭学校专业联系电话,漯河回流生正规价格,渭南复读冲刺提分快,西安应届生提分有哪些

A scary situation in Seguin, Texas, came to a peaceful end when an off-duty police officer apprehended a man who was wearing a surgical mask, carrying a handgun and acting erratically.According to the Seguin Police Department, the officer approached Tony Dwayne Albert II on Sunday after concerned bystanders reported Albert for suspicious behavior. The officer noted that Albert was "wearing tactical style clothing, a surgical face shield, carrying a loaded firearm and extra ammunition."An SPD spokeswoman said Albert claimed he was headed to an unidentified church to fulfill what he called a "prophecy."Albert, 33, of Houston, was arrested and charged with unlawful possession of a firearm by a felon.He was being held Monday at the Guadalupe County Jail on a 0,000 bond, according to online records. CNN has not been able to contact his attorney.Employees at a Mexican restaurant in Seguin 911

Across the country, 86 percent of police departments are dealing with an officer shortage. Half of those departments report the shortage has gotten worse in the last five years.“I grew up in a police family,” said Captain Nick Augustine with the Montgomery County Police Department. “I always saw the police car in the drive way, and it was always a career I wanted to go towards.”Augustine followed his father’s footsteps, put on a badge, and joined the force in 2001. He joined at a time when it was common to have legacy officers, meaning officers who were second or third generation police. However, with the declining number of people joining police departments, that has changed. “We may have one or two applicants who come from the law enforcement family that are actually applying to be a police officer,” said Augustine. As a captain in the Montgomery County Police Department, heading up the personnel division,Augustine has seen the shortage firsthand. The shortage in both legacy officers and the shortage in the number of people join the force altogether.The shortage at MCPD began in 2014. In August of that year, MCPD had 1,400 applicants for that academy class. The next class had only 600 applicants, which was a 58 percent reduction.“That was alarming,” said Augustine. “We were still able to fill our class at that point, but over the last couple of session, that has dropped where we haven’t been able to fill classes.”Any of the departments around the country, like Seattle and Miami, are dealing with shortages at a similar rate as MCPD. Adding to that, many departments are also seeing a rise in the number of officers resigning within the first five years on the job.“Looking at reasons why our numbers are dropping, the economy right now is very strong with low unemployment numbers,” explained Augustine. “Veterans--which we tend to have apply to be law enforcement officers--are now being offered private contracting jobs, which is paying higher than a government job.”Surveys from multiple police research organizations show recent controversial events and public perception of police officers have also played a role in the shortage.To combat this, departments have increased recruitment efforts. MCPD has place billboards outside their county and streamlined the police officer application process.“This is a rewarding career,” Augustine said. “You never know how many people you affect in the community by your actions.” 2463

A Texas police officer shot his adult son Saturday, thinking he was an intruder.Dispatchers received a call around 6 p.m. CDT from a man reporting a shooting at his home. The man said he was an off-duty Dallas officer who mistook his son for an intruder and accidentally shot him, according to a release from the DeSoto Police Department. DeSoto is a city south of Dallas.When officers arrived on scene, they found the victim bleeding from his right forearm. The victim was taken to a hospital with non-life-threatening injuries, the release said."It was a startling situation, it was an accident," Pete Schulte, DeSoto police spokesman, told 655

Actress Lori Loughlin turned herself in on Wednesday to authorities, one day after federal officials accused the actress and her husband of being involved in a major bribery scheme involving parents using bribes to help their children gain entry into elite colleges without merit. Loughlin posted a million bail on Wednesday, the LA Times reported. Loughlin, who was on the cast of the hit 90s sitcom "Full House," is accused of spending 0,000 in bribes to help her two daughters gain admission into USC. Loughlin's daughters allegedly gained entrance into USC as crew recruits, despite not having the credentials to participate in the sport. Fellow actress Felicity Huffman was also among those indicted on Tuesday. She was accused of paying ,000 to a fictitious charity, and in return, would allow her daughter to take the SAT with a proctor who would then alter the answers to the SAT. Huffman was released on a 0,000 bail on Wednesday. Neither actress has gone to trial yet. 1004

A pinch in the leg, a squeal and a trickle of tears. One baby after another in Malawi is getting the first and only vaccine against malaria, one of history’s deadliest and most stubborn of diseases.The southern African nation is rolling out the shots in an unusual pilot program along with Kenya and Ghana. Unlike established vaccines that offer near-complete protection, this new one is only about 40% effective. But experts say it’s worth a try as progress against malaria stalls: Resistance to treatment is growing and the global drop in cases has leveled off. With the vaccine, the hope is to help small children through the most dangerous period of their lives. Spread by mosquito bites, malaria kills more than 400,000 people every year, two-thirds of them under 5 and most in Africa.Seven-month-old Charity Nangware received a shot on a rainy December day at a health clinic in the town of Migowi. She watched curiously as the needle slid into her thigh, then twisted up her face with a howl.“I’m very excited about this,” said her mother, Esther Gonjani, who herself gets malaria’s aches, chills and fever at least once a year and loses a week of field work when one of her children is ill. “They explained it wasn’t perfect, but I feel secure it will relieve the pain.”There is little escaping malaria -- “malungo” in the local Chichewa language -- especially during the five-month rainy season. Stagnant puddles, where mosquitoes breed, surround the homes of brick and thatch and line the dirt roads through tea plantations or fields of maize and sugar cane. In the village of Tomali, the nearest health clinic is a two-hour bike ride away. The longer it takes to get care, the more dangerous malaria can be. Teams from the clinic offer basic medical care during visits once or twice a month, bringing the malaria shot and other vaccines in portable coolers. Treating malaria takes up a good portion of their time during the rainy season, according to Daisy Chikonde, a local health worker.“If this vaccine works, it will reduce the burden,” she said.Resident Doriga Ephrem proudly said her 5-month-old daughter, Grace, didn’t cry when she got the malaria shot.When she heard about the vaccine, Ephrem said her first thought was “protection is here.” Health workers explained, however, that the vaccine is not meant to replace antimalarial drugs or the insecticide-treated bed net she unfolds every night as the sun sets and mosquitoes rise from the shadows. “We even take our evening meals inside the net to avoid mosquitoes,” she said.It took three decades of research to develop the new vaccine, which works against the most common and deadly of the five parasite species that cause malaria. The parasite’s complex life cycle is a huge challenge. It changes forms in different stages of infection and is far harder to target than germs.“We don’t have any vaccines against parasites in routine use. This is uncharted territory,” said Ashley Birkett, who directs PATH’s Malaria Vaccine Initiative, a nonprofit that helped drugmaker GlaxoSmithKline develop the shot, brand-named Mosquirix. The bite of an infected mosquito sends immature parasites called sporozoites into the bloodstream. If they reach the liver, they’ll mature and multiply before spewing back into the blood to cause malaria’s debilitating symptoms. At that point, treatment requires medicines that kill the parasites.Mosquirix uses a piece of the parasite — a protein found only on sporozoites’ surface — in hopes of blocking the liver stage of infection. When a vaccinated child is bitten, the immune system should recognize the parasite and start making antibodies against it.Scientists also are searching for next-generation alternatives. In the pipeline is an experimental vaccine made of whole malaria parasites dissected from mosquitoes’ salivary glands but weakened so they won’t make people sick. Sanaria Inc. has been testing its vaccine in adults, and is planning a large, late-stage study in Equatorial Guinea’s Bioko Island.And the U.S. National Institutes of Health soon will start initial tests of whether injecting people periodically with lab-made antibodies, rather than depending on the immune system to make them, could offer temporary protection during malaria season. Think of them as “potentially short-term vaccines,” NIH’s Dr. Robert Seder told a recent meeting of the American Society of Tropical Medicine and Hygiene.For now, only babies in parts of Malawi, Kenya and Ghana are eligible for the Mosquirix vaccine. After the vaccine was approved in 2015, the World Health Organization said it first wanted a pilot roll-out to see how well it worked in a few countries — in real-world conditions — before recommending that the vaccine be given more widely across Africa. “Everyone is looking forward to getting it,” said Temwa Mzengeza, who oversees Malawi’s vaccine programs. Those eager for the shots include her husband, whom she had to stop from trying to get them, she said.Mzengeza used to come down with malaria several times a year until she started following her own advice to sleep under a net every night. Unlike many other kinds of infections, people can get malaria repeatedly, building up only a partial immunity.In the pilot program that began last year, 360,000 children in the three countries are meant to be vaccinated annually. The first dose is given at about age 5 months and the final, fourth booster near the child’s second birthday.Experts say it is too early to know how well the vaccine is working. They’re watching for malaria deaths, severe infections and cases of meningitis, something reported during studies but not definitively linked to the vaccine.“To do something completely new for malaria is exciting,” said researcher Don Mathanga, who is leading the evaluation in Malawi. The rainy season has brought new challenges, making some rural roads impassable and complicating efforts to track down children due for a shot. So far in Malawi, the first dose reached about half of the children targeted, about 35,000. That dropped to 26,000 for the second dose and 20,000 for the third. That’s not surprising for a new vaccine, Mzengeza said. “It will pick up with time.”At the health clinic in Migowi in Malawi’s southern highlands, workers see signs of hope. Henry Kadzuwa explains the vaccine to mothers waiting at the clinic. He said there was a drop in malaria cases to 40 in the first five months of the program, compared to 78 in the same period in 2018.Even though he wishes his 3-year-old daughter, Angel, could receive the vaccine, “it’s protecting my community. It also makes my work easier,” Kadzuwa said. The Migowi area has one of the country’s highest rates of malaria, and a worn paper register in the clinic’s laboratory lists scores of cases.At the clinic, Agnes Ngubale said she had malaria several years ago and wants to protect her 6-month-old daughter, Lydia, from the disease.“I want her to be healthy and free,” she said. “I want her to be a doctor.”And she has memorized the time for Lydia’s second dose: “Next month, same date.”___Neergaard reported from Washington.___The Associated Press Health and Science Department receives 7200